The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma (Q35463482)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma |
scientific article |
Statements
1 reference
The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma (English)
1 reference
Jenny L Pokorny
1 reference
David Calligaris
1 reference
Shiv K Gupta
1 reference
Dennis O Iyekegbe
1 reference
Dustin Mueller
1 reference
Katrina K Bakken
1 reference
Brett L Carlson
1 reference
Mark A Schroeder
1 reference
Debra L Evans
1 reference
Zhenkun Lou
1 reference
Paul A Decker
1 reference
Jeanette E Eckel-Passow
1 reference
Vincenzo Pucci
1 reference
Bennett Ma
1 reference
Stuart D Shumway
1 reference
William F Elmquist
1 reference
Nathalie Y R Agar
1 reference
Jann N Sarkaria
1 reference
21 January 2015
1 reference
1 reference
21
1 reference
8
1 reference
1916-1924
1 reference
Identifiers
1 reference
1 reference
1 reference